IRIS
MADEDDU, Giordano
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.876
AS - Asia 7.855
EU - Europa 6.396
SA - Sud America 4.496
AF - Africa 317
Continente sconosciuto - Info sul continente non disponibili 30
OC - Oceania 27
AN - Antartide 1
Totale 36.998
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.531
BR - Brasile 4.029
SG - Singapore 3.498
IT - Italia 2.682
CN - Cina 1.861
UA - Ucraina 1.028
DE - Germania 702
HK - Hong Kong 664
VN - Vietnam 653
FR - Francia 453
FI - Finlandia 297
GB - Regno Unito 271
SE - Svezia 203
AR - Argentina 165
IN - India 153
CA - Canada 145
NL - Olanda 135
BD - Bangladesh 133
RU - Federazione Russa 133
TR - Turchia 127
IQ - Iraq 122
MX - Messico 114
ZA - Sudafrica 88
EC - Ecuador 85
PK - Pakistan 73
PL - Polonia 70
UZ - Uzbekistan 69
MA - Marocco 67
JP - Giappone 66
ES - Italia 62
CZ - Repubblica Ceca 60
VE - Venezuela 56
CO - Colombia 48
RO - Romania 45
NP - Nepal 43
BE - Belgio 41
ID - Indonesia 40
TN - Tunisia 40
AE - Emirati Arabi Uniti 39
KR - Corea 38
PY - Paraguay 34
KE - Kenya 32
AT - Austria 31
JO - Giordania 28
SA - Arabia Saudita 28
CH - Svizzera 27
AU - Australia 26
AZ - Azerbaigian 26
KZ - Kazakistan 23
UY - Uruguay 23
CL - Cile 22
IE - Irlanda 22
PE - Perù 22
RS - Serbia 22
IL - Israele 21
LT - Lituania 20
KG - Kirghizistan 19
PH - Filippine 17
DO - Repubblica Dominicana 16
JM - Giamaica 16
AL - Albania 15
DZ - Algeria 15
EG - Egitto 15
MY - Malesia 15
OM - Oman 15
PS - Palestinian Territory 15
SN - Senegal 15
EU - Europa 14
IR - Iran 14
BG - Bulgaria 13
CR - Costa Rica 13
LB - Libano 13
PA - Panama 13
XK - ???statistics.table.value.countryCode.XK??? 10
HU - Ungheria 9
AM - Armenia 8
BO - Bolivia 8
BY - Bielorussia 8
MD - Moldavia 8
ET - Etiopia 7
HN - Honduras 7
GR - Grecia 6
MK - Macedonia 6
NG - Nigeria 6
PT - Portogallo 6
A2 - ???statistics.table.value.countryCode.A2??? 5
BN - Brunei Darussalam 5
LU - Lussemburgo 5
QA - Qatar 5
SK - Slovacchia (Repubblica Slovacca) 5
AO - Angola 4
CI - Costa d'Avorio 4
LY - Libia 4
NI - Nicaragua 4
TT - Trinidad e Tobago 4
GA - Gabon 3
GT - Guatemala 3
KH - Cambogia 3
KW - Kuwait 3
SI - Slovenia 3
Totale 36.938
Salva come PNG Salva come JPEG
Città #
Dallas 9.386
Singapore 1.968
Chandler 1.265
San Jose 1.203
Hong Kong 657
Ashburn 634
Jacksonville 579
Beijing 455
Princeton 396
New York 329
São Paulo 263
Rome 254
Lauterbourg 241
Ho Chi Minh City 212
Munich 198
Nanjing 195
Dearborn 190
Los Angeles 189
Milan 176
Hanoi 163
Shanghai 155
Wilmington 155
Sassari 152
Santa Clara 136
Rio de Janeiro 130
Helsinki 128
Boardman 122
Belo Horizonte 114
Ann Arbor 106
Council Bluffs 91
Columbus 90
Nanchang 82
The Dalles 81
Brasília 77
Curitiba 71
Shenyang 70
Naples 66
Campinas 59
Tashkent 59
Orem 58
Tianjin 58
Tokyo 58
Brno 56
Porto Alegre 56
Cagliari 55
Warsaw 55
Florence 54
Frankfurt am Main 53
Denver 50
San Francisco 50
Woodbridge 48
Montreal 47
Buffalo 45
Changsha 43
Hebei 43
London 43
Baghdad 42
Brooklyn 42
Johannesburg 42
Toronto 42
Brussels 40
Nuremberg 40
Salvador 40
Fortaleza 39
Atlanta 37
Chennai 37
Guarulhos 37
Guayaquil 35
Jinan 35
Palermo 35
Phoenix 35
Seoul 34
Chicago 33
Mexico City 33
Manchester 32
Poplar 32
São José dos Campos 32
Dhaka 31
Goiânia 31
Zhengzhou 31
Da Nang 30
Guangzhou 30
Houston 30
São Bernardo do Campo 30
Turin 30
Turku 30
Nairobi 28
Amsterdam 27
Haiphong 27
Istanbul 27
Jiaxing 27
Santo André 27
Sorocaba 27
Amman 26
Lahore 26
Ningbo 26
Recife 26
Ribeirão Preto 26
Bologna 25
Norwalk 25
Totale 23.186
Salva come PNG Salva come JPEG
Nome #
CASE REPORT: MIOCARDITE ACUTA DA CITOMEGALOVIRUS IN GIOVANE PAZIENTE IMMUNOCOMPETENTE 2.001
Risk of clinical events in virologically suppressed people with HIV switching to a two-drug regimen vs. remaining on a three-drug regimen: a target trial emulation 838
Antifungal Agents in the 21st Century: Advances, Challenges, and Future Perspectives 652
All-cause and Cause-specific Mortality in People With HIV in Italy in 1997–2022: Data From the Icona Cohort 646
Tuberculosis-Induced Immune-Mediated Necrotizing Myopathy: A Challenging Case Scenario in a Non-Endemic Country 571
CD4/CD8 Ratio Increase in Female Living with HIV Switching to Cabotegravir-Rilpivirine: A Real-Life 24 Weeks Evaluation 535
Head-to-head: meropenem/vaborbactam versus ceftazidime/avibactam in ICUs patients with KPC-producing K. pneumoniae infections– results from a retrospective multicentre study 529
Neuropsychiatric adverse events in people with HIV initiating a new integrase strand transfer inhibitor-based regimen in Italy: findings from the NEURO-INSTI study 430
PARVOVIRUS B19 E POLIMIALGIA REUMATICA: THE BUTTERFLY EFFECT 373
Assessing the Accuracy, Completeness and Safety of ChatGPT-4o Responses on Pressure Injuries in Infants: Clinical Applications and Future Implications 280
Activation of MSRV-type endogenous retroviruses during infectious mononucleosis and Epstein-Barr virus latency: the missing link with multiple sclerosis? 279
Differences in HCV Seroprevalence, Clinical Features, and Treatment Outcomes between Female and Male Incarcerated Population: Results from a Matched Cohort Study 276
Clinical use of dalbavancin in the Italian SUSANA cohort (SUrveillance of SAfety and outcome of New Antibiotics) 265
How Little Do We Know about HIV and STIs Prevention? Results from a Web-Based Survey among the General Population 263
Safety and effectiveness of switch to bictegravir/emtricitabine/tenofovir alafenamide following dual regimen therapy in people with HIV: Insights from the Icona cohort 260
Efficacy and safety of B/F/TAF in naïve people with HIV: real life data from the SHiNeSHiC research group 254
Rare or Unusual Non-Fermenting Gram-Negative Bacteria: Therapeutic Approach and Antibiotic Treatment Options 250
Fluoroquinolones and Biofilm: A Narrative Review 238
Efficacy and tolerability of antiretroviral therapy: focus on people with HIV or on PrEP 226
Alendronate reduces bone resorption in HIV-associated osteopenia/osteoporosis 223
Question and answers on long-acting therapy with cabotegravir and rilpivirine in people with HIV 219
Enzyme biosensors for biomedical applications: Strategies for safeguarding analytical performances in biological fluids 219
99mTc-tetrofosmin SPECT in solitary pulmonary nodule evaluation 213
Activation of MSRV-type endogenous retroviruses during infectious mononucleosis and Epstein-Barr virus latency: the missing link with multiple sclerosis? 213
A case of vasculitis-like skin eruption associated with COVID-19 206
Activation of endogenous retroviruses of the HERV-W family by Epstein Barr virus in vitro and in vivo: a dual virus model as the missing link with multiple sclerosis 206
Underserved populations and bacterial and protozoal sexually transmitted infections: a lost health-care opportunity 197
The use of nucleoside reverse transcriptase inhibitors sparing regimens in treatment-experienced HIV-1 infected patients 194
Ebola virus disease: Case management in the Institute of Infectious Diseases, University Hospital of Sassari, Sardinia, Italy. 190
Analisi delle Dual Therapy nei pazienti con HIV: Aspetti farmacoeconomici-epidemiologici e clinici 190
Active Case Finding for Communicable Diseases in Prison Settings: Increasing Testing Coverage and Uptake Among the Prison Population in the European Union/European Economic Area 188
A longitudinal Study on body compositionin HIV –infected patients receiving HAART. 183
Epidemiology, Clinical Aspects, Laboratory Diagnosis and Treatment of Rickettsial Diseases in the Mediterranean Area During COVID-19 Pandemic: A Review of the Literature 182
Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial. 176
Mucocutaneous leishmniasis as presentation of HIV infection in Sardinia, insular Italy 175
Dalbavancin two dose regimen for the treatment of prosthetic joint infections: new possible options for difficult to treat infectious diseases 174
HEPATOCELLULAR CARCINOMA DEVELOPMENT IN A PATIENT WITH HCV INFECTION AFTER ERADICATION WITH DIRECT-ACTING ANTIVIRAL AGENTS 173
Acute respiratory distress syndrome due to influenza virus A/H1N1v in a patient with HIV/HCV co-infection 172
Alexithymia Predicts Carotid Atherosclerosis, Vascular Events, and All-Cause Mortality in Human Immunodeficiency Virus-Infected Patients: An Italian Multisite Prospective Cohort Study 169
Bacterial community acquired pneumonia in HIV-infected inpatients in the highly active antiretroviral therapy era 167
Does Angiotensin II receptor blockers increase the risk of SARS-CoV-2 infection? A real-life experience 166
Olfactory and gustatory function impairment in COVID-19 patients: Italian objective multicenter-study 166
Correlations between IL-6 serum level and olfactory dysfunction severity in COVID-19 patients: a preliminary study 166
A systematic review on models of care effectiveness and barriers to Hepatitis C treatment in prison settings in the EU/EEA 164
Clinical features, laboratory findings and predictors of death in hospitalized patients with COVID-19 in Sardinia, Italy 160
The additional role of 18F-FDG PET/CT in prosthetic valve endocarditis 160
The burden of HIV-Associated neurocognitive disorder (HAND) in post-HAART era: Amultidisciplinary review of the literature 160
Body fat changes in HIV patients on highly active antiretroviral therapy (HAART): a longitudinal DEXA study 157
Targeted therapies in cholangiocarcinoma: emerging evidence from clinical trials 157
Adverse skin reactions in course of combined antiretroviral therapy 156
The De Ritis ratio as prognostic biomarker of in-hospital mortality in COVID-19 patients 155
Assessing ChatGPT’s Potential in HIV Prevention Communication: A Comprehensive Evaluation of Accuracy, Completeness, and Inclusivity 153
Correlations Between Olfactory Psychophysical Scores and SARS-CoV-2 Viral Load in COVID-19 Patients 152
Mitochondrial toxicity and body shape changes during nucleos(t)ide analogues administration in patients with chronic hepatitis B 150
Bone mass loss and vitamin D metabolism impairment in HIV patients receiving highly active antiretroviral therapy 149
Immune response induced by Epstein-Barr virus and Mycobacterium avium subsp. paratuberculosis peptides in current and past infectious mononucleosis: a risk for multiple sclerosis? 149
Natalizumab therapy modulates miR-155, miR-26a and proinflammatory cytokine expression in MS patients 149
Trends in the European HIV/AIDS epidemic: a perspective from Italy 149
Meningite linfomatosa in un paziente con linfoma plasmoblastico del cavo orale HIV-relato: ruolo della citarabina liposomiale. 148
Body fat changes in HIV patients on highly active antiretroviral therapy (HAART): a longitudinal DEXA study. 147
Cytological and histological diagnosis of lung cancer in Sardinia and Italy in the 1990s 146
Tenofovir renal safety in HIV-infected patients: results from the SCOLTA Project 144
Mood Reactive Disorders among COVID-19 Inpatients: Experience from a Monocentric Cohort 144
Somatostatin receptor scintigraphy with 111In-pentetreotide in non-functioning gastroenteropancreatic neuroendocrine tumors 142
Early treatment with low-molecular-weight heparin reduces mortality rate in SARS-CoV-2 patients 142
Body composition change in hiv-infected patients treated with HAART: a longitudinal DEXA study. 141
Pneumococcal pneumonia: clinical features, diagnosis and management in HIV-infected and HIV non infected patients 140
Chronic viral hepatitis in the italian prison setting: Prevalence, outcomes, literature needs and perspectives 140
Editorial - Non AIDS-defining malignancies: a new epidemic in HIV-infected population for the upcoming decades? 139
Positioning of darunavir/cobicistat-containing antiretroviral regimens in real life: Results from a large multicentre observational prospective cohort (SCOLTA) 139
Bacterial community-acquired pneumonia in HIV-infected patients 139
Chronic obstructive pulmonary disease: an emerging comorbidity in HIV-infected patients in the HAART era? 139
Assessing ChatGPT’s theoretical knowledge and prescriptive accuracy in bacterial infections: a comparative study with infectious diseases residents and specialists 138
Arboviral infections in Egyptian and Sardinian children and adults with aseptic meningitis and meningo-encephalitis 137
Objective evaluation of anosmia and ageusia in COVID-19 patients: Single-center experience on 72 cases 137
QuantiFERON TB Gold: a new method for latent tuberculosis infection 137
DNMT1 modulation in chronic hepatitis B patients and hypothetic influence on mitochondrial DNA methylation status during long-term nucleo(t)side analogs therapy 137
Body composition evaluation by DEXA in the follow up of HIV patients treted with HAART. 137
Kidney disease in HIV-infected patients. 135
Utilizzo di EVG/COBI/FTC/TDF in una paziente con viremia elevata e cirrosi HCV-correlata 134
Body fat changes and mitochondrial alterations during HBV treatment: A warning for long term administration. 134
Hepatic echinococcosis: clinical and therapeutic aspects. 134
Effectiveness of Vitamin D Supplements among Patients Hospitalized for COVID-19: Results from a Monocentric Matched-Cohort Study 134
Proteomic characterization of hepatitis C eradication: enzyme switch in the healing liver. 133
Tuberculosis Screening before Anti–Hepatitis C Virus Therapy in Prisons 131
Treatment with direct-acting antivirals in a multicenter cohort of HCV-infected inmates in Italy 131
Patient-Reported Outcomes in an Observational Cohort of HIV-1-Infected Adults on Darunavir/Cobicistat-Based Regimens: Beyond Viral Suppression 131
Reduced risk of death in people with SARS-CoV-2 infection treated with remdesivir: a nested case-control study 130
HIV Infection Indicator Disease-Based Active Case Finding in a University Hospital: Results from the SHOT Project 129
Safety and efficacy of molnupiravir in SARS-CoV-2-infected patients: A real-life experience 129
Simplification to atazanavir/ritonavir+lamivudine in virologically suppressed HIV-infected patients: 24-weeks interim analysis from ATLAS-M trial. 129
Neurocognitive performance and cardiovascular risk in a cohort of HIV-infected patients 129
Circulation of SARS-CoV-2 Among Asylum Seekers: A Real-Life Experience to Address Health Equity in Piacenza, Italy 128
Vaccinations in prison settings: A systematic review to assess the situation in EU/EEA countries and in other high income countries 128
Use of bedaquiline in spinal osteomyelitis and soft tissue abscess caused by multidrug-resistant Mycobacterium tuberculosis: A case report 127
The HIV treatment and care cascade in Italy: successes and disparities 127
Coronavirus disease 2019 (COVID-19)–related smell and taste impairment with widespread diffusion of severe acute respiratory syndrome–coronavirus-2 (SARS-CoV-2) Omicron variant 127
Predictors of incomplete viral response and virologic failure in patients with acute and early HIV infection. Results of Italian Network of ACuTe HIV InfectiON (INACTION) cohort 126
CD4 cell count and the risk of infective and non-infective serious non-AIDS events in HIV-positive persons seen for care in Italy. 125
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial 125
Totale 21.682
Salva come PNG Salva come JPEG
Categoria #
all - tutte 129.641
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 129.641
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202136 0 0 0 0 0 0 0 0 0 0 0 36
2021/20221.109 130 29 26 26 26 32 40 63 83 72 143 439
2022/20232.522 239 209 68 414 208 404 37 274 402 47 130 90
2023/20241.209 139 72 56 40 293 114 35 79 17 48 101 215
2024/20259.092 150 144 492 308 492 405 674 1.560 2.882 1.231 517 237
2025/202618.937 655 3.112 7.385 1.796 1.431 625 1.840 371 580 689 338 115
Totale 37.558